Press release
microRNA Industry Poised for Rapid Expansion, Forecasted CAGR of 29.4% from 2023 to 2033 - Analysis by TMR
MicroRNA Market
Explore the highlights and essential data from our Report in this sample - https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1515
Market Overview
The global microRNA market has seen a significant rise in demand, driven by the need for advanced diagnostic tools and targeted therapies. In 2023, the global sales of the microRNA market stood at US$ 1.2 billion. Due to the increasing adoption of microRNA-based technologies in research and clinical applications, the market is expected to grow at a CAGR of 29.4% from 2023 to 2033, reaching an estimated value of US$ 15.5 billion by 2033. Key factors propelling market growth include advancements in proteomics and genomics, increased clinical trials, and the rising prevalence of chronic diseases.
Market Size and Growth
Between 2018 and 2022, the microRNA market experienced a compound annual growth rate (CAGR) of approximately 24.6%. This robust growth was primarily driven by increased research funding, rising biotech startups, and the development of innovative microRNA-based therapies. From 2023 to 2033, the market is expected to accelerate further, fueled by the growing acceptance of microRNA in clinical and preclinical research. The consumables segment is projected to be the highest revenue-generating category, with an anticipated CAGR of over 28.5% during the forecast period.
Competitive Landscape
The microRNA market is highly competitive, with key players focusing on technological advancements, strategic partnerships, and product innovations to gain a competitive edge. Major companies operating in the market include Thermo Fisher Scientific Inc., Miltenyi Biotec, and NanoString. These players are investing heavily in research and development to enhance their microRNA profiling technologies and expand their product portfolios. Additionally, companies are emphasizing inorganic growth strategies, such as mergers and acquisitions, to strengthen their market presence, particularly in developing regions.
Discover valuable insights and findings from our Report in this sample - https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1515
Market Segmentation
The microRNA market is segmented based on services, products, applications, and end-users:
By Services: Includes isolation & purification, cDNA synthesis, profiling, localization & quantification, and functional analysis.
By Products: Comprises instruments and consumables, with consumables leading the segment due to their frequent replacement needs.
By Application: Encompasses cancer, infectious diseases, immunological disorders, cardiovascular diseases, neurological diseases, and others.
By End-Use: Covers biotechnology & pharmaceutical companies, academic & government research institutes, and other sectors.
Regional Analysis
North America: In 2022, North America accounted for the largest share of the microRNA market, driven by an increasing number of clinical trials and high healthcare spending in the United States. The U.S. market is projected to reach a valuation of US$ 6.7 billion by 2033.
Asia Pacific: This region is expected to witness the fastest growth due to a larger patient pool, rising adoption of microRNA-based treatments, and expanding medical research in countries like China, India, and Singapore.
Europe: The U.K. microRNA market is anticipated to reach US$ 440 million by 2033, with a significant absolute dollar opportunity.
Rest of the World: Increasing healthcare expenditure and technological advancements in the Middle East, Latin America, and Africa contribute to market growth in these regions.
Future Outlook
The future of the microRNA market looks promising, with ongoing research, clinical trials, and technological innovations driving its expansion. The rising number of pharma and biotech firms investing in microRNA-based therapeutics is expected to create lucrative opportunities for market players. However, challenges such as safety concerns and regulatory hurdles could hinder market growth. Despite these obstacles, advancements in RNA sequencing, biomarker discovery, and personalized medicine will likely continue to propel the microRNA market forward, making it a crucial component of modern healthcare and diagnostics.
Buy this Premium Research Report to access comprehensive analysis - https://www.transparencymarketresearch.com/checkout.php?rep_id=1515<ype=S
More Trending Reports by Transparency Market Research -
Animal Genetics Market: https://www.transparencymarketresearch.com/animal-genetics-market.html
Coagulation Testing Market: https://www.transparencymarketresearch.com/coagulation-testing-market.html
About Transparency Market Research
Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
Contact:
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com
Email: sales@transparencymarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release microRNA Industry Poised for Rapid Expansion, Forecasted CAGR of 29.4% from 2023 to 2033 - Analysis by TMR here
News-ID: 3905917 • Views: …
More Releases from Transparency Market Research
Global Solar Powered Agricultural Dryer Market to Exceed USD 2.4 Billion by 2031 …
The global solar powered agricultural dryer market, valued at US$ 1.6 billion in 2022, is projected to grow at a CAGR of 5.8% from 2023 to 2031, reaching US$ 2.4 billion by the end of 2031. Rising investments in renewable energy, growing awareness of sustainable agricultural practices, and the rapid expansion of the agricultural sector driven by population growth are key factors fueling market growth.
Uncover essential discoveries and trends from…
Technetium-99m Market Forecast 2034: Rising Demand for Diagnostic Imaging and Ra …
The global Technetium‐99m Market was valued at US$ 6.0 Billion in 2023 and is projected to grow at a CAGR of 3.3% from 2024 to 2034, surpassing US$ 8.6 Billion by the end of the forecast period. Advancements in nuclear imaging infrastructure, government-backed healthcare initiatives, and an increasing demand for precise diagnostic procedures are fueling this growth.
Discover essential conclusions and data from our Report in this sample -
https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=77100
Analysts' Viewpoint
The Technetium‐99m…
Equine Diagnostic Services Market Outlook 2030: From US$ 168 Million in 2019 to …
The global Equine Diagnostic Services Market, valued at approximately US$ 168 million in 2019, is projected to expand at a compound annual growth rate (CAGR) of ~5% from 2020 to 2030, reaching around US$ 280 million by 2030. Equine diagnostic services, encompassing tests like genetic, infectious disease, and imaging diagnostics, are critical for managing horse health in veterinary hospitals, clinics, and mobile settings. The market is driven by increasing equine…
Digital Printing Market to Reach USD 54.4 Billion by 2034, Growing at a CAGR of …
The digital printing market is experiencing strong growth, driven by rapid technological advancements, rising demand for personalized and on-demand printing, and an increasing focus on sustainable solutions. Digital printing allows for the direct transfer of digital files onto a wide range of substrates, offering high-resolution output with greater speed and flexibility. Its adaptability has led to broad adoption across industries such as packaging, textiles, publishing, and advertising-sectors where customization, efficiency,…
More Releases for RNA
CD Formulation Launches Custom Circular RNA Synthesis Service to Accelerate RNA …
CD Formulation introduces a customizable circRNA synthesis service, delivering high-quality, stable circRNAs for therapeutics, vaccines, and gene research, supported by advanced design and QC processes.
CD Formulation, a leading provider of advanced small nucleic acid synthesis [https://www.formulationbio.com/nucleic-acid/custom-small-nucleic-acid-synthesis.html] solutions, is proud to announce the launch of its fully customizable circular RNA (circRNA) synthesis service. This new service addresses the growing need for stable, non-immunogenic RNA molecules for therapeutic development, vaccine research, and…
Self-Amplifying RNA Synthesis Market Gains Traction as Biotech Firms Embrace Sca …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the " Self-Amplifying RNA Synthesis Market- (By Product & Service (Products (Enzymes & Reagents, Premade saRNA, Others), Custom Synthesis Services), By Application (Therapeutics Development (Oncology, Infectious Diseases, Others), Biomedical Research), By End-User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Others)), Trends, Industry Competition Analysis, Revenue and Forecast To 2034."
According to the latest research by InsightAce Analytic,…
RNA Extraction and RNA Purification Market: Growth, Trends & Competitive Landsca …
The global RNA Extraction and RNA Purification Market is expected to grow at 6.3% CAGR from 2025 to 2032.
This Market Report is the result of extensive research and analysis conducted by our team of experienced market researchers through -
• 70% efforts of Primary Research
• 15% efforts of Secondary Research
• 15% efforts from the subscription to Paid database providing industry overview, macro and micro economics factors, and financials of private limited…
RNA Targeting Small Molecules Therapeutics Market: Exponential Growth with Risin …
Estimations Predict a CAGR of 29.8% by 2029 in Global RNA Targeting Small Molecules Therapeutics Market Boosted by Precision Medicine, RNA Biomarker Identification and RNA Genetic Manipulation
What Is The Projected Market Size of The Global RNA Targeting Small Molecules Therapeutics Market And Its Growth Rate?
• The market will grow from $6.1 billion in 2024 to $7.87 billion in 2025 at a compound annual growth rate (CAGR) of 28.9%.
• Expected exponential…
Global DNARNA Extraction Kit Market by Type (Cell-free DNA (cfDNA), Sequence-spe …
"DNARNA Extraction Kit Market" is segmented by Company, Region (country), By Type, Application, stakeholders and other participants. This report provides an analysis of revenue and forecast across Type and Application segments for 2023-2032.
The market for DNARNA Extraction Kits has been thoroughly researched via primary and secondary sources to produce this research study. Along with a competitive analysis of the market, segmented by application, type, and geographical trends, it offers a…
Cancer RNA Expression Market to Reap Excessive Revenues by 2028(By sequencing te …
Worldwide cancer is one of the leading cause of death and effective way of treating it still looks unaccomplished in most parts of the world. The factors which influence the successful treatment of cancer are different depending on the stage of diagnosis, treatment availability and availability of trained healthcare professionals coupled with high economic burden of the disease. The gene expression of cancerous cells varies by cancer type and may…
